2025
SJR Q1
JCR Q2 · 3,1
173 matched articles
SCIE
Journal detail
Experimental Eye Research
- Publisher
- Academic Press
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0014483510960007
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,887
- Quartile Q1
- H-Index 162
- Cites/doc 3,32
- Docs (3y) 942
- Cites (3y) 3.415
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,1
- 5Y JIF 3,7
- JCI 1,24
WoS indexes
- SCIE
Subject classification
Categories (SJR)
Areas
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,887 | 3,1 | 3,7 | 1,24 | Q1 | 162 |
| 2024 | Q1 | Q2 | 0,965 | 2,7 | 3,3 | 1,35 | Q1 | 153 |
| 2023 | Q1 | Q1 | 1,02 | 3 | 3,3 | 1,45 | Q1 | 153 |
| 2022 | Q1 | Q2 | 0,933 | 3,4 | 3,6 | 1,47 | Q1 | 153 |
| 2021 | Q1 | Q2 | 0,858 | 3,8 | 4 | 1,37 | Q1 | 153 |
| 2020 | Q1 | Q2 | 1,217 | 3,5 | 3,8 | 1,43 | Q1 | 153 |
| 2019 | Q1 | Q1 | 1,139 | 3 | 3,1 | 1,45 | Q1 | 153 |
| 2018 | — | Q1 | — | 3 | 3,3 | 1,43 | Q1 | — |
| 2017 | Q1 | Q1 | 1,449 | 3,2 | 3,3 | 1,4 | Q1 | 153 |
| 2016 | Q1 | Q1 | 1,331 | 3,3 | 3,2 | — | — | 153 |
| 2015 | Q1 | Q1 | 1,243 | 3 | 3 | — | — | 153 |
| 2014 | Q1 | Q1 | 1,237 | 2,7 | 3 | — | — | 153 |
| 2013 | Q1 | Q1 | 1,335 | 3 | 3,1 | — | — | 153 |
| 2012 | Q1 | Q1 | 1,444 | 3 | 3,1 | — | — | 153 |
| 2011 | Q1 | Q1 | 1,307 | 3,3 | 3,1 | — | — | 153 |
| 2010 | Q1 | Q1 | 1,234 | 2,8 | 3 | — | — | 153 |
| 2009 | — | Q1 | — | 2,5 | 2,8 | — | — | — |
| 2008 | — | Q1 | — | 2,6 | 2,9 | — | — | — |
| 2007 | — | Q1 | — | 2,7 | 2,9 | — | — | — |
| 2006 | — | Q1 | — | 2,8 | — | — | — | — |
| 2005 | — | Q1 | — | 2,7 | — | — | — | — |
| 2004 | — | Q1 | — | 2,8 | — | — | — | — |
| 2003 | — | Q1 | — | 2,6 | — | — | — | — |
| 2002 | — | Q1 | — | 2 | — | — | — | — |
| 2001 | — | Q1 | — | 2,2 | — | — | — | — |
| 2000 | — | Q1 | — | 2 | — | — | — | — |
| 1999 | — | Q1 | — | 2 | — | — | — | — |
| 1998 | — | Q1 | — | 2,1 | — | — | — | — |
| 1997 | — | Q1 | — | 2,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | OPHTHALMOLOGY | SCIE | Q2 | Q1 | 25/98 |
| 2024 | OPHTHALMOLOGY | SCIE | Q2 | Q1 | 25/99 |
| 2023 | OPHTHALMOLOGY | SCIE | Q1 | Q1 | 18/95 |
| 2022 | OPHTHALMOLOGY | SCIE | Q2 | Q1 | 16/62 |
| 2021 | OPHTHALMOLOGY | SCIE | Q2 | Q1 | 21/62 |
| 2020 | OPHTHALMOLOGY | SCIE | Q2 | Q1 | 17/62 |
| 2019 | OPHTHALMOLOGY | SCIE | Q1 | Q1 | 12/60 |
| 2018 | OPHTHALMOLOGY | SCIE | Q1 | Q1 | 14/60 |
| 2017 | OPHTHALMOLOGY | SCIE | Q1 | Q1 | 14/59 |
| 2016 | OPHTHALMOLOGY | SCIE | Q1 | — | 10/59 |
| 2015 | OPHTHALMOLOGY | SCIE | Q1 | — | 13/56 |
| 2014 | OPHTHALMOLOGY | SCIE | Q1 | — | 14/57 |
| 2013 | OPHTHALMOLOGY | SCIE | Q1 | — | 9/58 |
| 2012 | OPHTHALMOLOGY | SCIE | Q1 | — | 6/59 |
| 2011 | OPHTHALMOLOGY | SCIE | Q1 | — | 8/58 |
| 2010 | OPHTHALMOLOGY | SCIE | Q1 | — | 11/56 |
| 2009 | OPHTHALMOLOGY | SCIE | Q1 | — | 12/49 |
| 2008 | OPHTHALMOLOGY | SCIE | Q1 | — | 12/48 |
| 2007 | OPHTHALMOLOGY | SCIE | Q1 | — | 9/45 |
| 2006 | OPHTHALMOLOGY | SCIE | Q1 | — | 7/45 |
| 2005 | OPHTHALMOLOGY | SCIE | Q1 | — | 7/44 |
| 2004 | OPHTHALMOLOGY | SCIE | Q1 | — | 7/42 |
| 2003 | OPHTHALMOLOGY | SCIE | Q1 | — | 7/41 |
| 2002 | OPHTHALMOLOGY | SCIE | Q1 | — | 10/41 |
| 2001 | OPHTHALMOLOGY | SCIE | Q1 | — | 8/43 |
| 2000 | OPHTHALMOLOGY | SCIE | Q1 | — | 9/41 |
| 1999 | OPHTHALMOLOGY | SCIE | Q1 | — | 8/43 |
| 1998 | OPHTHALMOLOGY | SCIE | Q1 | — | 5/42 |
| 1997 | OPHTHALMOLOGY | SCIE | Q1 | — | 4/39 |